Docoh
Loading...

Tue. 23 Nov 2021, 9:37am ETBenzinga
In: News, Price Target, Initiation, Analyst Ratings
BTIG analyst Robert Hazlett initiates coverage on Aura Biosciences (NASDAQ:AURA) with a Buy rating and announces Price Target of $38.